688075 安旭生物
2024/09 - 九个月2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)2.6472.68875.84743.2121.330
总资产报酬率 ROA (%)2.3442.22259.51633.71298.405
投入资产回报率 ROIC (%)2.5282.52970.57740.40068.427

边际利润分析
销售毛利率 (%)42.11042.29874.78265.44575.911
营业利润率 (%)35.71033.27357.23254.43263.498
息税前利润/营业总收入 (%)37.35214.47948.42655.85666.250
净利润/营业总收入 (%)33.66228.00549.37146.46954.093

收益指标分析
经营活动净收益/利润总额(%)9.11942.170119.289101.392101.154
价值变动净收益/利润总额(%)78.45059.3151.3921.3810.166
营业外收支净额/利润总额(%)0.001-16.457-0.265-0.052-0.050

偿债能力分析
流动比率 (X)8.9638.7884.5694.5333.581
速动比率 (X)8.6618.4284.4244.1623.135
资产负债率 (%)11.20511.81122.04420.54426.271
带息债务/全部投入资本 (%)1.8822.4893.7826.720--
股东权益/带息债务 (%)5,104.9243,815.5472,465.1861,379.4013,063.419
股东权益/负债合计 (%)793.021747.187353.842386.752280.648
利息保障倍数 (X)22.744-1.027-5.59638.45423.799

营运能力分析
应收账款周转天数 (天)150.442155.98222.02986.6060.000
存货周转天数 (天)208.426244.44251.010121.1610.000